During the past decade, Ospedale Vito Fazzi conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 13 clinical trials were completed, i.e. on average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 7 clinical trials were completed. i.e. 31.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Vito Fazzi" #1 sponsor was "National Cancer Institute, Naples" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Consorzio Oncotech" with 4 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored and "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 4 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Vito Fazzi" #1 collaborator was "Clinical Research Technology S.r.l." with 5 trials as a collaborator, "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 2 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator, "Gruppo Oncologico Italia Meridionale" with 2 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Vito Fazzi" are "Heart Failure" (7 trials), "Metastatic Breast Cancer" (5 trials), "Breast Cancer" (4 trials), "Acute Myeloid Leukemia" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (3 trials). Many other conditions were trialed in "Ospedale Vito Fazzi" in a lesser frequency.

Most popular intervention types in "Ospedale Vito Fazzi" are "Drug" (62 trials), "Device" (10 trials), "Other" (10 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (4 trials), "Prednisone" (4 trials), "Bevacizumab" (3 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Vito Fazzi" are 67 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Vito Fazzi". undefined are not yet recruiting, 16 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Ospedale Vito Fazzi, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Vito Fazzi, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Ospedale Vito Fazzi has several departments that took part in Clinical trials: "Ospedale San Giuseppe Da Copertino, U.O. Di Cardiologia-Utic" - 5 trials, "Presidio Ospedaliero F. Ferrari - Cardiologia - Utic" - 3 trials, "Ospedale Santa Caterina Novella - U.O. Di Cardiologia" - 2 trials